|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
treatment |
ISO |
DNA:haplotype: :3435T>C((rs1045642), 2677T>G (rs2032582) (human) DNA:SNP: : rs10276036(human) |
RGD |
PMID:23372834 PMID:24517233 |
RGD:39456119, RGD:11098698 |
NCBI chr 4:26,312,403...26,488,456
|
|
G |
Arhgap44 |
Rho GTPase activating protein 44 |
disease_progression |
ISO |
DNA:SNPs, haplotype:intron, exon: (rs2072255, rs2072254) (human) DNA:SNP:intron: (rs2072255) (human) |
RGD |
PMID:28069446 PMID:21107268 |
RGD:401901288, RGD:401901289 |
NCBI chr10:49,655,583...49,822,876
|
|
G |
Bst2 |
bone marrow stromal cell antigen 2 |
|
ISO |
DNA:SNPs: : |
RGD |
PMID:26885809 |
RGD:14398494 |
NCBI chr16:18,216,605...18,220,979
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
|
ISO |
DNA:SNP:3' utr:rs1719153 (human) |
RGD |
PMID:16773571 |
RGD:5683896 |
NCBI chr10:68,963,893...68,965,728
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
|
ISO |
ClinVar Annotator: match by term: Acquired immunodeficiency syndrome, delayed progression to |
ClinVar |
PMID:9742978 PMID:12610055 PMID:12815099 |
|
NCBI chr 8:132,629,097...132,660,980
|
|
G |
Cd209d |
CD209d molecule |
disease_progression |
ISO |
associated with factor VIII deficiency; DNA:SNP:promoter: g.-139C>T (rs2287886) (human) |
RGD |
PMID:17530998 |
RGD:39939010 |
NCBI chr12:1,891,109...1,897,559
|
|
G |
Cd4 |
Cd4 molecule |
|
ISO |
associated with drug dependence; protein:increased expression:temporal lobe (human) |
RGD |
PMID:16873198 |
RGD:407420271 |
NCBI chr 4:159,355,147...159,381,636
|
|
G |
Cd40lg |
CD40 ligand |
treatment |
ISO |
|
RGD |
PMID:9499800 |
RGD:11344976 |
NCBI chr X:140,164,341...140,176,057
|
|
G |
Cd68 |
Cd68 molecule |
|
ISO |
associated with drug dependence; protein:increased expression:temporal lobe (human) |
RGD |
PMID:16873198 |
RGD:407420271 |
NCBI chr10:54,880,562...54,882,441
|
|
G |
Cd8a |
CD8 subunit alpha |
|
ISO |
associated with drug dependence; protein:increased expression:temporal lobe (human) |
RGD |
PMID:16873198 |
RGD:407420271 |
NCBI chr 4:104,924,116...104,928,353
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
susceptibility |
ISO |
DNA:polymorphism:exon:p.K751Q(human) |
RGD |
PMID:20127180 |
RGD:5688740 |
NCBI chr 1:88,161,342...88,175,102
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
|
ISO |
associated with pulmonary tuberculosis;protein:increased expression:blood (human) |
RGD |
PMID:32369456 |
RGD:39939073 |
NCBI chr16:74,133,259...74,145,328
|
|
G |
Ifna1 |
interferon, alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9612607 |
|
NCBI chr 5:103,097,356...103,097,925
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Acquired immunodeficiency syndrome, rapid progression to |
CTD ClinVar |
PMID:9612607 PMID:12854077 |
|
NCBI chr 7:55,789,180...55,793,216
|
|
G |
Igf2 |
insulin-like growth factor 2 |
|
ISO |
protein:decreased expression:plasma |
RGD |
PMID:11232005 |
RGD:5509969 |
NCBI chr 1:197,814,409...197,831,802
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:9861562 |
|
NCBI chr 2:121,932,968...121,937,672
|
|
G |
Kir3dl1 |
killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1 |
severity |
ISO |
DNA:missense mutation:cds: p.I47V (rs643347) (human) |
RGD |
PMID:29461980 |
RGD:38676267 |
NCBI chr 1:69,715,529...69,754,050
|
|
G |
Ncr1 |
natural cytotoxicity triggering receptor 1 |
|
ISO |
protein:decreased expression:peripheral blood mononuclear cell,natural killer cell (human) |
RGD |
PMID:27382604 |
RGD:40818276 |
NCBI chr 1:78,657,409...78,665,255
|
|
G |
Ncr3 |
natural cytotoxicity triggering receptor 3 |
|
ISO |
protein:decreased expression:peripheral blood mononuclear cell,natural killer cell (human) |
RGD |
PMID:27382604 |
RGD:40818276 |
NCBI chr20:3,637,242...3,643,748
|
|
G |
RT1-CE15 |
RT1 class I, locus CE15 |
susceptibility |
ISO |
DNA:polymorphism: :HLA-A31 |
RGD |
PMID:19030725 |
RGD:36049809 |
NCBI chr20:3,275,575...3,279,074
|
|
G |
RT1-CE16 |
RT1 class I, locus CE16 |
susceptibility |
ISO |
DNA:polymorphism: :HLA-A31 |
RGD |
PMID:19030725 |
RGD:36049809 |
NCBI chr20:3,261,656...3,265,548
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
|
RGD |
PMID:8548330 |
RGD:12904035 |
NCBI chr20:3,626,685...3,629,303
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
ISO |
|
RGD |
PMID:8548330 |
RGD:12904035 |
NCBI chr 4:159,837,119...159,849,817
|
|
G |
Tnfrsf1b |
TNF receptor superfamily member 1B |
|
ISO |
|
RGD |
PMID:8548330 |
RGD:12904035 |
NCBI chr 5:157,070,642...157,104,216
|
|
G |
Vdr |
vitamin D receptor |
|
ISO |
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr 7:130,864,764...130,916,757
|
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27400929 |
|
NCBI chr18:57,912,760...57,914,802
|
|
G |
Epo |
erythropoietin |
treatment |
ISO |
|
RGD |
PMID:20818790 |
RGD:10395393 |
NCBI chr12:19,204,258...19,207,948
|
|
G |
Gc |
GC, vitamin D binding protein |
|
ISO |
associated with HIV Infections;protein:increased expression:cerebrospinal fluid: |
RGD |
PMID:17929958 |
RGD:5509882 |
NCBI chr14:18,632,146...18,667,563
|
|
G |
Il1b |
interleukin 1 beta |
|
IEP |
protein:increased expression:neocortex |
RGD |
PMID:17678975 |
RGD:1626641 |
NCBI chr 3:137,030,200...137,036,581
|
|
G |
Insr |
insulin receptor |
severity |
ISO |
protein:increased expression:cerebrospinal fluid, plasma |
RGD |
PMID:22629383 |
RGD:10403033 |
NCBI chr12:5,991,135...6,129,275
|
|
G |
Irs1 |
insulin receptor substrate 1 |
severity |
ISO |
protein:decreased tyrosine phosphorylation:cerebrospinal fluid, leukocyte |
RGD |
PMID:22629383 |
RGD:10403033 |
NCBI chr 9:91,001,137...91,053,959
|
|
G |
Nefl |
neurofilament light chain |
|
ISO |
associated with HIV Seropositivity;protein:increased expression:plasma, CSF (human) protein:increased expression:CSF (human) |
RGD |
PMID:30105502 PMID:27400930 |
RGD:127284876, RGD:127284885 |
NCBI chr15:46,477,330...46,481,203
|
|
G |
Npy |
neuropeptide Y |
severity |
ISO |
protein:increased expression:cerebrospinal fluid |
RGD |
PMID:8815163 |
RGD:10431910 |
NCBI chr 4:80,212,111...80,219,310
|
|
G |
Oprm1 |
opioid receptor, mu 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27400929 |
|
NCBI chr 1:45,565,371...45,818,722
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
ISO |
|
RGD |
PMID:21368226 |
RGD:6482787 |
NCBI chr 7:113,419,882...113,438,343
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
|
ISO |
|
RGD |
PMID:25404050 |
RGD:38676266 |
NCBI chr10:62,322,688...62,357,060
|
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
|
ISO |
|
RGD |
PMID:2 |
RGD:1303381 |
NCBI chr17:34,383,397...34,435,523
|
|
G |
Agtr2 |
angiotensin II receptor, type 2 |
|
ISO |
|
RGD |
PMID:2 |
RGD:1303381 |
NCBI chr X:116,914,320...116,918,504
|
|
G |
Egf |
epidermal growth factor |
|
ISO |
|
RGD |
PMID:19357719 |
RGD:6906909 |
NCBI chr 2:220,893,660...220,976,331
|
|
G |
Hp |
haptoglobin |
|
ISO |
protein:increased expression:urine |
RGD |
PMID:19279121 |
RGD:11041816 |
NCBI chr19:54,449,151...54,453,701
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
|
ISO |
|
RGD |
PMID:23678040 PMID:23678040 |
RGD:7245474, RGD:7245474 |
NCBI chr 5:164,167,985...164,277,438
|
|
G |
Myh9 |
myosin, heavy chain 9 |
|
ISO |
protein:decreased expression:glomerulus |
RGD |
PMID:22313957 |
RGD:6903274 |
NCBI chr 7:111,224,291...111,304,963
|
|
G |
Notch4 |
notch receptor 4 |
|
IEP |
protein: increased expression: kidney |
RGD |
PMID:20706108 |
RGD:6480788 |
NCBI chr20:4,160,362...4,184,466
|
|
G |
Nphs1 |
NPHS1 adhesion molecule, nephrin |
treatment |
ISO |
|
RGD |
PMID:19188342 PMID:17229913 |
RGD:38596324, RGD:38599164 |
NCBI chr 1:85,720,812...85,749,079
|
|
|
G |
Klrk1 |
killer cell lectin like receptor K1 |
treatment |
ISO |
|
RGD |
PMID:23018378 |
RGD:39018554 |
NCBI chr 4:163,079,887...163,092,434
|
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10861090 |
|
NCBI chr13:23,204,464...23,366,900
|
|
|
G |
Cd4 |
Cd4 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9546790 |
|
NCBI chr 4:159,355,147...159,381,636
|
|
G |
Tnfrsf8 |
TNF receptor superfamily member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9379333 |
|
NCBI chr 5:157,123,183...157,168,421
|
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
|
ISO |
protein:decreased expression:skin |
RGD |
PMID:17545018 |
RGD:7483603 |
NCBI chr 9:91,837,139...91,839,736
|
|
G |
Cd8a |
CD8 subunit alpha |
|
ISO |
mRNA:decreased expression:zone of skin (human) |
RGD |
PMID:25774455 |
RGD:36174028 |
NCBI chr 4:104,924,116...104,928,353
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr 9:69,812,859...69,819,959
|
|
G |
Foxp3 |
forkhead box P3 |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr X:17,580,380...17,601,181
|
|
G |
Ifna1 |
interferon, alpha 1 |
treatment |
ISO |
|
RGD |
PMID:25774455 |
RGD:36174028 |
NCBI chr 5:103,097,356...103,097,925
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr13:45,024,921...45,029,586
|
|
G |
Il12b |
interleukin 12B |
treatment |
ISO |
protein:decreased expression:peripheral blood mononuclear cells (human) |
RGD |
PMID:16114559 PMID:23754510 |
RGD:7829774, RGD:40400714 |
NCBI chr10:29,390,300...29,405,194
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
protein:decreased expression:peripheral blood mononuclear cells (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr 2:121,932,968...121,937,672
|
|
G |
Il21 |
interleukin 21 |
|
ISO |
protein:decreased expression:blood serum (human) |
RGD |
PMID:31414711 |
RGD:127285371 |
NCBI chr 2:120,117,105...120,127,012
|
|
G |
Il4 |
interleukin 4 |
treatment |
ISO |
protein:increased expression:peripheral blood mononuclear cells (human) |
RGD |
PMID:16114559 PMID:23754510 |
RGD:7829774, RGD:40400714 |
NCBI chr10:38,272,003...38,277,549
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
protein:decreased expression:peripheral blood mononuclear cells (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr 4:5,889,999...5,894,575
|
|
G |
Klrk1 |
killer cell lectin like receptor K1 |
|
ISO |
mRNA,protein:decreased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr 4:163,079,887...163,092,434
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
treatment |
ISO |
mRNA:increased expression:zone of skin (human) |
RGD |
PMID:25774455 |
RGD:36174028 |
NCBI chr16:8,645,171...8,728,225
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr 8:127,952,161...127,956,230
|
|
G |
Ncr1 |
natural cytotoxicity triggering receptor 1 |
|
ISO |
mRNA,protein:decreased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr 1:78,657,409...78,665,255
|
|
G |
Pdcd1 |
programmed cell death 1 |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr 9:101,866,124...101,879,278
|
|
G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
|
ISO |
protein:increased expression:foreskin |
RGD |
PMID:18543080 |
RGD:39128248 |
NCBI chr12:41,026,079...41,085,577
|
|
G |
Ptpn6 |
protein tyrosine phosphatase, non-receptor type 6 |
|
ISO |
protein:increased expression:foreskin |
RGD |
PMID:18543080 |
RGD:39128248 |
NCBI chr 4:159,212,320...159,237,069
|
|
G |
Serpinf1 |
serpin family F member 1 |
disease_progression |
ISO |
mRNA, protein:decreased expression:skin of body (human) |
RGD |
PMID:23569025 |
RGD:27226706 |
NCBI chr10:60,250,198...60,262,593
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr 1:90,324,312...90,340,627
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr 2:171,499,189...171,504,831
|
|
G |
Tlr3 |
toll-like receptor 3 |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr16:53,554,916...53,572,321
|
|
G |
Tlr4 |
toll-like receptor 4 |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr 5:85,161,247...85,174,882
|
|
G |
Tlr7 |
toll-like receptor 7 |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr X:30,644,324...30,670,796
|
|
G |
Tlr8 |
toll-like receptor 8 |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr X:30,708,714...30,733,104
|
|
G |
Tlr9 |
toll-like receptor 9 |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr 8:115,743,407...115,747,523
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
protein:increased expression:peripheral blood mononuclear cells (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr20:3,626,685...3,629,303
|
|
G |
Tnfrsf18 |
TNF receptor superfamily member 18 |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr 5:171,901,734...171,904,578
|
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
|
ISO |
mRNA:increased expression:perianal skin (human) |
RGD |
PMID:20346172 |
RGD:152998971 |
NCBI chr 8:13,253,697...13,273,672
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
ISO |
mRNA:increased expression:perianal skin (human) |
RGD |
PMID:20346172 |
RGD:152998971 |
NCBI chr 8:13,285,702...13,313,329
|
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
|
ISO |
|
RGD |
PMID:16118671 |
RGD:8549760 |
NCBI chr 8:132,629,097...132,660,980
|
|
G |
Cd40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:20102413 |
RGD:5132268 |
NCBI chr 3:174,209,113...174,224,592
|
|
G |
Foxp3 |
forkhead box P3 |
treatment |
ISO |
|
RGD |
PMID:30832593 |
RGD:38455984 |
NCBI chr X:17,580,380...17,601,181
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:19728926 |
RGD:4145507 |
NCBI chr 8:27,829,688...27,841,618
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
treatment |
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:30832593 PMID:31249813 |
RGD:38455984, RGD:39938856 |
NCBI chr16:74,133,259...74,145,328
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19203382 |
|
NCBI chr 7:55,789,180...55,793,216
|
|
G |
Il13 |
interleukin 13 |
|
ISO |
|
RGD |
PMID:21573182 |
RGD:5684365 |
NCBI chr10:38,290,926...38,293,483
|
|
G |
Il17a |
interleukin 17A |
|
ISO |
associated with Bronchial Hyprractivity; mRNA:increased expression:lung |
RGD |
PMID:20228193 PMID:19812198 |
RGD:4888528, RGD:4889101 |
NCBI chr 9:30,640,844...30,644,331
|
|
G |
Mir21 |
microRNA 21 |
|
ISO |
associated with asthma;RNA:increased expression:lung |
RGD |
PMID:27448447 |
RGD:41404696 |
NCBI chr10:71,902,600...71,902,691
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
treatment |
ISO |
|
RGD |
PMID:30832593 |
RGD:38455984 |
NCBI chr 1:90,324,312...90,340,627
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19203382 |
|
NCBI chr20:3,626,685...3,629,303
|
|
|
G |
Cd274 |
CD274 molecule |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:26378990 |
RGD:41412180 |
NCBI chr 1:236,526,215...236,549,956
|
|
G |
Pdcd1 |
programmed cell death 1 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:26378990 |
RGD:41412180 |
NCBI chr 9:101,866,124...101,879,278
|
|
G |
Pik3cd |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
severity |
ISO |
|
RGD |
PMID:29893841 |
RGD:40890270 |
NCBI chr 5:165,377,994...165,426,620
|
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
ISO |
ClinVar Annotator: match by term: Coronary artery disease, development of, in HIV |
ClinVar |
PMID:11500196 PMID:15466648 PMID:16352737 PMID:16596675 PMID:18940815 |
|
NCBI chr10:67,503,077...67,504,875
|
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO |
|
RGD |
PMID:12502811 |
RGD:4890015 |
NCBI chr10:68,820,330...68,824,906
|
|
G |
Ifnar1 |
interferon alpha and beta receptor subunit 1 |
exacerbates |
ISO |
|
RGD |
PMID:28264883 |
RGD:125093738 |
NCBI chr11:30,725,774...30,752,227
|
|
G |
Ifng |
interferon gamma |
|
ISO |
protein:increased expression:vaginal secretion: |
RGD |
PMID:10366565 |
RGD:8158034 |
NCBI chr 7:55,789,180...55,793,216
|
|
G |
Il21 |
interleukin 21 |
treatment |
ISO |
|
RGD |
PMID:24358128 |
RGD:127285365 |
NCBI chr 2:120,117,105...120,127,012
|
|
G |
Il3 |
interleukin 3 |
|
ISO |
RNA: increased expression |
RGD |
PMID:21175248 |
RGD:5686876 |
NCBI chr10:38,906,460...38,908,810
|
|
G |
Irf9 |
interferon regulatory factor 9 |
exacerbates |
ISO |
|
RGD |
PMID:28264883 |
RGD:125093738 |
NCBI chr15:29,095,474...29,101,924
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
ameliorates |
ISO |
|
RGD |
PMID:31555293 |
RGD:42722615 |
NCBI chr 3:81,001,529...81,031,165
|
|
G |
Rnasel |
ribonuclease L |
severity |
ISO |
|
RGD |
PMID:17157346 |
RGD:40902623 |
NCBI chr13:68,446,641...68,460,804
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
treatment severity |
ISO |
DNA:SNP:intron:rs7572482 (human) DNA:SNPs, haplotype: :multiple |
RGD |
PMID:22718836 PMID:22718836 |
RGD:8661697, RGD:8661697 |
NCBI chr 9:49,472,660...49,588,540
|
|
|
G |
App |
amyloid beta precursor protein |
|
ISO |
|
RGD |
PMID:29632166 |
RGD:13782045 |
NCBI chr11:37,506,207...37,724,351
|
|
G |
Bace1 |
beta-secretase 1 |
|
ISO |
|
RGD |
PMID:29632166 |
RGD:13782045 |
NCBI chr 8:55,038,842...55,061,138
|
|
G |
Cd68 |
Cd68 molecule |
|
ISO |
protein:increased expression:brain (human) |
RGD |
PMID:15488024 |
RGD:40925943 |
NCBI chr10:54,880,562...54,882,441
|
|
G |
Cdk5 |
cyclin-dependent kinase 5 |
|
IDA |
protein:increased tyrosine phosphorylation:hippocampus |
RGD |
PMID:28107387 |
RGD:13506927 |
NCBI chr 4:11,647,098...11,651,606
|
|
G |
Mfn1 |
mitofusin 1 |
|
ISO |
associated with HIV Infections;protein:increased expression:frontal cortex, membrane (human) |
RGD |
PMID:26611103 |
RGD:12910851 |
NCBI chr 2:115,313,380...115,359,651
|
|
G |
Olig2 |
oligodendrocyte transcription factor 2 |
|
ISO |
|
RGD |
PMID:15579294 |
RGD:40902823 |
NCBI chr11:30,475,510...30,478,886
|
|
|
G |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17209195 |
|
NCBI chr14:17,891,564...17,907,043
|
|
G |
Aph1b |
aph-1 homolog B, gamma secretase subunit |
susceptibility |
ISO |
DNA:SNP:CDS:p.F217L (rs1047552) (human) |
RGD |
PMID:19774691 |
RGD:13703126 |
NCBI chr 8:67,429,198...67,454,735
|
|
G |
Clec4m |
C-type lectin domain family 4 member M |
susceptibility |
ISO |
DNA:repeats:exon 4 DNA:repeat: |
RGD |
PMID:25656622 PMID:20217198 PMID:16453266 |
RGD:11520989, RGD:39938989, RGD:39938979 |
NCBI chr12:1,915,902...1,924,529
|
|
G |
Klrk1 |
killer cell lectin like receptor K1 |
|
ISO |
protein:increased expression:peripheral blood mononuclear cell,natural killer cell (human) |
RGD |
PMID:27091211 |
RGD:40818300 |
NCBI chr 4:163,079,887...163,092,434
|
|
G |
Ncr1 |
natural cytotoxicity triggering receptor 1 |
treatment |
ISO |
protein:decreased expression:peripheral blood mononuclear cell, natural killer cell (human) |
RGD |
PMID:18724804 PMID:27091211 |
RGD:40818277, RGD:40818300 |
NCBI chr 1:78,657,409...78,665,255
|
|
G |
Nefl |
neurofilament light chain |
treatment |
ISO |
|
RGD |
PMID:30105502 |
RGD:127284876 |
NCBI chr15:46,477,330...46,481,203
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
|
ISO |
DNA:polymorphism (human) |
RGD |
PMID:20224785 |
RGD:5147578 |
NCBI chr20:4,548,664...4,558,237
|
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7979221 |
|
NCBI chr 3:136,979,804...136,990,236
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7979221 |
|
NCBI chr 3:137,030,200...137,036,581
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7979221 |
|
NCBI chr 4:5,889,999...5,894,575
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7979221 |
|
NCBI chr20:3,626,685...3,629,303
|
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
|
RGD |
PMID:12876073 |
RGD:8694470 |
NCBI chr11:91,226,524...91,240,244
|
|
G |
Adrb3 |
adrenoceptor beta 3 |
|
ISO |
DNA:missense mutation:cds:p.W64R rs4994 (human) |
RGD |
PMID:10930169 |
RGD:5684895 |
NCBI chr16:64,839,820...64,844,552
|
|
G |
Il18 |
interleukin 18 |
susceptibility |
ISO |
DNA:SNPs, haplotype:promoter:-137G>C (rs187238), -607C>A (rs1946518) (human) |
RGD |
PMID:20331838 PMID:15353983 |
RGD:8655915, RGD:8655934 |
NCBI chr 8:59,802,072...59,829,275
|
|
G |
Lmna |
lamin A/C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18230615 |
|
NCBI chr 2:176,237,564...176,265,301
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
|
ISO |
DNA:SNP |
RGD |
PMID:20852404 |
RGD:8549721 |
NCBI chr 8:12,943,453...12,963,966
|
|
G |
Zmpste24 |
zinc metallopeptidase STE24 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18230615 |
|
NCBI chr 5:139,912,395...139,945,532
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
treatment severity |
IEP ISO |
mRNA:altered expression:brain, heart, kidney (rat) DNA:SNPs: :4036A>G, 1236C>T (human) |
RGD |
PMID:24472536 PMID:23133441 PMID:27334660 |
RGD:11041168, RGD:39456100, RGD:39456096 |
NCBI chr 4:26,312,403...26,488,456
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
|
IDA IEP |
mRNA:decreased expression, increased expression:brain, kidney (rat) |
RGD |
PMID:16790532 PMID:24472536 |
RGD:1598562, RGD:11041168 |
NCBI chr 4:26,197,706...26,280,156
|
|
G |
Abce1 |
ATP binding cassette subfamily E member 1 |
|
ISO |
DNA:mutations:multiple (human) |
RGD |
PMID:19657357 |
RGD:11041871 |
NCBI chr19:28,205,566...28,230,489
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27400929 |
|
NCBI chr18:57,912,760...57,914,802
|
|
G |
Aicda |
activation-induced cytidine deaminase |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:30219203 |
RGD:127285639 |
NCBI chr 4:157,446,120...157,455,958
|
|
G |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16903978 |
|
NCBI chr14:17,891,564...17,907,043
|
|
G |
Alyref |
Aly/REF export factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr10:105,871,424...105,875,076
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12646808 |
|
NCBI chr 8:55,423,945...55,425,729
|
|
G |
Arap3 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr18:29,806,214...29,834,217
|
|
G |
Arhgap4 |
Rho GTPase activating protein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr X:151,636,071...151,651,528
|
|
G |
Arhgdia |
Rho GDP dissociation inhibitor alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr10:106,352,858...106,356,347
|
|
G |
Arhgdib |
Rho GDP dissociation inhibitor beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 4:171,554,139...171,573,057
|
|
G |
Atm |
ATM serine/threonine kinase |
|
ISO |
protein:decreased expression:T cell (human) |
RGD |
PMID:31781094 |
RGD:126790561 |
NCBI chr 8:62,724,939...62,829,040
|
|
G |
Bag3 |
BAG cochaperone 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17187345 |
|
NCBI chr 1:192,533,460...192,557,281
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12878215 |
|
NCBI chr 1:105,076,472...105,081,906
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12878215 |
|
NCBI chr 8:13,253,697...13,273,672
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12878215 |
|
NCBI chr 8:13,285,702...13,313,329
|
|
G |
Bst2 |
bone marrow stromal cell antigen 2 |
|
ISO |
ClinVar Annotator: match by term: Human immunodeficiency virus type 1, rapid progression to AIDS |
ClinVar |
|
|
NCBI chr16:18,216,605...18,220,979
|
|
G |
C3 |
complement C3 |
|
ISO |
|
RGD |
PMID:7561187 |
RGD:11040775 |
NCBI chr 9:2,174,412...2,201,339
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Human immunodeficiency virus type 1, susceptibility to CTD Direct Evidence: marker/mechanism protein:increased expression:plasma |
ClinVar OMIM CTD RGD |
PMID:14571188 PMID:27246604 |
RGD:14995461 |
NCBI chr10:67,525,975...67,530,576
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
ISO |
ClinVar Annotator: match by term: Human immunodeficiency virus type 1, susceptibility to protein:increased expression:plasma CTD Direct Evidence: marker/mechanism |
ClinVar CTD RGD |
PMID:14571188 PMID:27246604 |
RGD:14995461 |
NCBI chr10:67,503,077...67,504,875
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
OMIM CTD |
|
|
NCBI chr10:68,948,889...68,950,439
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
susceptibility |
ISO |
|
RGD |
PMID:16250882 |
RGD:5683897 |
NCBI chr10:68,963,893...68,965,728
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO |
ClinVar Annotator: match by term: Human immunodeficiency virus type 1, delayed disease progression with infection by | ClinVar Annotator: match by term: Human immunodeficiency virus type 1, rapid disease progression with infection by CTD Direct Evidence: marker/mechanism |
ClinVar CTD OMIM |
PMID:10200305 PMID:12114533 PMID:12610055 |
|
NCBI chr10:68,820,330...68,824,906
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Human immunodeficiency virus type 1, susceptibility to |
CTD OMIM ClinVar |
PMID:9252328 PMID:9662369 PMID:25741868 |
|
NCBI chr 8:132,611,883...132,619,106
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10202824 |
|
NCBI chr 8:123,586,100...123,634,178
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
|
ISO |
protein:decreased expression:blood, T cell (human) ClinVar Annotator: match by term: Human immunodeficiency virus type 1, increased perinatal transmission of | ClinVar Annotator: match by term: Human immunodeficiency virus type 1, susceptibility to CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD RGD |
PMID:8639485 PMID:8751444 PMID:8756719 PMID:9055842 PMID:9132277 PMID:9140404 PMID:9207783 PMID:9399903 PMID:9433423 PMID:9466996 PMID:9511755 PMID:9585595 PMID:9600249 PMID:9742978 PMID:9768627 PMID:10520641 PMID:10559343 PMID:10615909 PMID:10803840 PMID:11081537 PMID:11369664 PMID:11403804 PMID:11403814 PMID:11517319 PMID:11781692 PMID:12610055 PMID:12815099 PMID:12874407 PMID:15744032 PMID:15863470 PMID:16216086 PMID:16248677 PMID:16418398 PMID:19017985 PMID:19073967 PMID:28492532 PMID:33116287 PMID:16379602 More...
|
RGD:4892094 |
NCBI chr 8:132,629,097...132,660,980
|
|
G |
Cct3 |
chaperonin containing TCP1 subunit 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 2:173,765,701...173,790,353
|
|
G |
Cct5 |
chaperonin containing TCP1 subunit 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 2:84,302,621...84,313,773
|
|
G |
Cct7 |
chaperonin containing TCP1 subunit 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 4:119,546,730...119,563,973
|
|
G |
Cd163 |
CD163 molecule |
exacerbates treatment |
ISO |
protein:increased expression:blood plasma (human) |
RGD |
PMID:23916293 PMID:24594990 |
RGD:127285682, RGD:149735575 |
NCBI chr 4:157,085,080...157,118,470
|
|
G |
Cd209d |
CD209d molecule |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Human immunodeficiency virus type 1, susceptibility to |
CTD OMIM ClinVar |
PMID:15564514 PMID:15838506 PMID:16379498 PMID:25741868 |
|
NCBI chr12:1,891,109...1,897,559
|
|
G |
Cd274 |
CD274 molecule |
|
ISO |
|
RGD |
PMID:30161254 PMID:30236481 |
RGD:41412179, RGD:41412181 |
NCBI chr 1:236,526,215...236,549,956
|
|
G |
Cd28 |
Cd28 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7492435 |
|
NCBI chr 9:69,660,316...69,689,192
|
|
G |
Cd40 |
CD40 molecule |
|
ISO |
protein:increased expression:plasmacytoid dendritic cell |
RGD |
PMID:20559432 |
RGD:5490533 |
NCBI chr 3:174,209,113...174,224,592
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO |
|
RGD |
PMID:21177803 |
RGD:5490598 |
NCBI chr X:140,164,341...140,176,057
|
|
G |
Cd68 |
Cd68 molecule |
disease_progression |
ISO |
associated with opioid use;protein:increased expression:brain (human) |
RGD |
PMID:22797933 |
RGD:41404655 |
NCBI chr10:54,880,562...54,882,441
|
|
G |
Cd8a |
CD8 subunit alpha |
treatment |
ISO |
|
RGD |
PMID:29384862 |
RGD:124715453 |
NCBI chr 4:104,924,116...104,928,353
|
|
G |
Cdc42 |
cell division cycle 42 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 5:154,838,478...154,876,629
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12878215 |
|
NCBI chr20:7,150,820...7,161,373
|
|
G |
Clic1 |
chloride intracellular channel 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr20:3,769,522...3,778,367
|
|
G |
Cops6 |
COP9 signalosome subunit 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr12:17,038,979...17,041,818
|
|
G |
Cr2 |
complement C3d receptor 2 |
|
ISO |
protein:decreased expression:B cell |
RGD |
PMID:8442917 |
RGD:127338249 |
NCBI chr13:109,207,034...109,244,980
|
|
G |
Crp |
C-reactive protein |
disease_progression |
ISO |
|
RGD |
PMID:22448211 |
RGD:6482303 |
NCBI chr13:87,694,062...87,695,978
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
|
ISO |
ClinVar Annotator: match by term: Human immunodeficiency virus type 1, susceptibility to CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD |
PMID:25741868 |
|
NCBI chr 8:128,661,294...128,679,048
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:27246604 |
RGD:14995461 |
NCBI chr14:15,989,066...15,991,263
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: CXCL12-related condition | ClinVar Annotator: match by term: Human immunodeficiency virus type 1, susceptibility to |
OMIM CTD ClinVar |
PMID:9430590 PMID:25741868 |
|
NCBI chr 4:152,060,781...152,073,628
|
|
G |
Cxcr1 |
C-X-C motif chemokine receptor 1 |
|
ISO |
ClinVar Annotator: match by term: CXCR1-related condition | ClinVar Annotator: match by term: Human immunodeficiency virus type 1, susceptibility to CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD |
PMID:18550579 PMID:25741868 PMID:28492532 |
|
NCBI chr 9:83,216,040...83,220,225
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
treatment |
ISO |
DNA:haplotype: :CYP2B6*6(human) DNA:SNPs: :516G>T,983T>C (human) |
RGD |
PMID:21862974 PMID:18281305 |
RGD:11098366, RGD:11097175 |
NCBI chr 1:90,780,468...90,859,852
|
|
G |
Ddx1 |
DEAD-box helicase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24183723 |
|
NCBI chr 6:35,996,469...36,027,340
|
|
G |
Ddx3x |
DEAD-box helicase 3, X-linked |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24183723 |
|
NCBI chr X:9,479,532...9,493,169
|
|
G |
Dnajc7 |
DnaJ heat shock protein family (Hsp40) member C7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr10:86,018,977...86,055,419
|
|
G |
Eif3b |
eukaryotic translation initiation factor 3, subunit B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr12:19,310,308...19,334,768
|
|
G |
Eif4a1 |
eukaryotic translation initiation factor 4A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr10:54,883,093...54,888,602
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr16:71,495,457...71,508,845
|
|
G |
Eif6 |
eukaryotic translation initiation factor 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 3:144,325,038...144,331,396
|
|
G |
Emg1 |
EMG1 N1-specific pseudouridine methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 4:157,509,258...157,517,540
|
|
G |
Ephb2 |
Eph receptor B2 |
|
ISO |
mRNA:decreased expression:Anterior cingulate |
RGD |
PMID:23314923 |
RGD:127285026 |
NCBI chr 5:154,179,065...154,360,459
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
|
RGD |
PMID:10200468 |
RGD:11049451 |
NCBI chr 1:241,212,155...241,245,774
|
|
G |
Fcer2 |
Fc epsilon receptor II |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11500085 |
|
NCBI chr12:1,742,809...1,754,476
|
|
G |
Fcgr3a |
Fc gamma receptor 3A |
susceptibility |
ISO |
DNA:polymorphism:exon:p.F158V(rs396991)(human) |
RGD |
PMID:21187939 |
RGD:5508390 |
NCBI chr13:85,782,636...85,792,656
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12878215 |
|
NCBI chr 4:97,484,497...97,486,799
|
|
G |
Gc |
GC, vitamin D binding protein |
disease_progression |
ISO |
|
RGD |
PMID:2883392 |
RGD:5509934 |
NCBI chr14:18,632,146...18,667,563
|
|
G |
Grpel1 |
GrpE-like 1, mitochondrial |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr14:74,292,023...74,298,243
|
|
G |
Gtf3a |
general transcription factor III A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr12:13,250,643...13,258,587
|
|
G |
Hdgf |
heparin binding growth factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 2:173,370,147...173,379,756
|
|
G |
Hp |
haptoglobin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16597321 |
|
NCBI chr19:54,449,151...54,453,701
|
|
G |
Hsp90aa1 |
heat shock protein 90 alpha family class A member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12878215 |
|
NCBI chr 6:135,523,604...135,529,687
|
|
G |
Hsp90ab1 |
heat shock protein 90 alpha family class B member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 9:22,930,249...22,935,929
|
|
G |
Hspa9 |
heat shock protein family A (Hsp70) member 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr18:26,536,131...26,554,294
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12878215 |
|
NCBI chr12:26,430,640...26,432,301
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 9:64,073,610...64,084,332
|
|
G |
Hsph1 |
heat shock protein family H (Hsp110) member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr12:5,390,916...5,410,224
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD OMIM |
PMID:10202824 |
|
NCBI chr 7:55,789,180...55,793,216
|
|
G |
Il10 |
interleukin 10 |
treatment susceptibility |
ISO |
ClinVar Annotator: match by term: Human immunodeficiency virus type 1, susceptibility to CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD RGD |
PMID:10202824 PMID:11121048 PMID:14657422 PMID:14657427 PMID:18550579 PMID:25741868 PMID:28492532 PMID:10666520 More...
|
RGD:7365087 |
NCBI chr13:45,024,921...45,029,586
|
|
G |
Il15 |
interleukin 15 |
|
ISO |
protein:decreased expression:plasma |
RGD |
PMID:20028198 |
RGD:4892672 |
NCBI chr19:42,536,160...42,611,349
|
|
G |
Il17d |
interleukin 17D |
severity |
ISO |
Protein:increased expression:blood plasma (human) |
RGD |
PMID:28592538 |
RGD:40903074 |
NCBI chr15:31,671,337...31,688,833
|
|
G |
Il18 |
interleukin 18 |
treatment |
ISO |
protein:increased expression:serum: associated with hepatitis C; protein:increased expression:serum: |
RGD |
PMID:27927859 PMID:27927859 |
RGD:14696653, RGD:14696653 |
NCBI chr 8:59,802,072...59,829,275
|
|
G |
Il19 |
interleukin 19 |
|
ISO |
ClinVar Annotator: match by term: Human immunodeficiency virus type 1, susceptibility to |
ClinVar |
PMID:11121048 PMID:14657422 PMID:14657427 PMID:18550579 PMID:25741868 PMID:28492532 More...
|
|
NCBI chr13:42,397,715...42,411,637
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12878215 |
|
NCBI chr 2:121,932,968...121,937,672
|
|
G |
Il21 |
interleukin 21 |
|
ISO |
associated with hepatitis B;protein:decreased expression:blood serum (human) |
RGD |
PMID:22948268 |
RGD:127285366 |
NCBI chr 2:120,117,105...120,127,012
|
|
G |
Il21r |
interleukin 21 receptor |
|
ISO |
|
RGD |
PMID:22530560 |
RGD:6892924 |
NCBI chr 1:180,168,028...180,195,690
|
|
G |
Il27 |
interleukin 27 |
ameliorates |
ISO |
protein:increased expression:blood plasma (human) associated with hepatitis C;protein:increased expression:blood plasma (human) |
RGD |
PMID:28338007 PMID:24816922 |
RGD:126790518, RGD:126790553 |
NCBI chr 1:181,173,108...181,178,720
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12878215 |
|
NCBI chr17:66,849,974...66,898,665
|
|
G |
Il4r |
interleukin 4 receptor |
|
ISO |
ClinVar Annotator: match by term: Human immunodeficiency virus type 1, susceptibility to |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr 1:180,115,061...180,139,981
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:1768380 |
RGD:10449449 |
NCBI chr 4:5,889,999...5,894,575
|
|
G |
Ilf2 |
interleukin enhancer binding factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 2:178,256,927...178,268,773
|
|
G |
Ipo7 |
importin 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 1:173,497,472...173,537,707
|
|
G |
Kir3dl1 |
killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1 |
susceptibility |
ISO |
DNA:deletion:cds CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17496894 PMID:31863692 |
RGD:38676444 |
NCBI chr 1:69,715,529...69,754,050
|
|
G |
Kmt2e |
lysine methyltransferase 2E |
|
ISO |
protein:increased expression:peripheral blood, T cell, CD4+ (human) |
RGD |
PMID:16046540 |
RGD:9588555 |
NCBI chr 4:12,550,570...12,655,329
|
|
G |
Kpnb1 |
karyopherin subunit beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr10:82,145,662...82,174,437
|
|
G |
Lck |
LCK proto-oncogene, Src family tyrosine kinase |
|
IDA |
protein:increased tyrosine phosphorylation:T cell |
RGD |
PMID:16828835 |
RGD:1600221 |
NCBI chr 5:147,172,642...147,201,267
|
|
G |
Lepr |
leptin receptor |
|
ISO |
protein:increased phosphorylation:peripheral blood mononuclear cell |
RGD |
PMID:12100031 |
RGD:21079471 |
NCBI chr 5:121,409,735...121,593,201
|
|
G |
Lyn |
LYN proto-oncogene, Src family tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 5:21,437,127...21,553,097
|
|
G |
Map2 |
microtubule-associated protein 2 |
|
ISO |
|
RGD |
PMID:19966940 |
RGD:6483319 |
NCBI chr 9:75,173,038...75,431,606
|
|
G |
Maz |
MYC associated zinc finger protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 1:181,629,742...181,635,193
|
|
G |
Mbl2 |
mannose binding lectin 2 |
no_association severity |
ISO |
CTD Direct Evidence: marker/mechanism DNA:polymorphism:exon: |
CTD RGD |
PMID:16960176 PMID:26348711 PMID:19796822 |
RGD:12910931, RGD:12910857 |
NCBI chr 1:237,429,873...237,465,567
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12878215 |
|
NCBI chr 7:55,176,558...55,201,757
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
|
ISO |
|
RGD |
PMID:21576701 |
RGD:6483531 |
NCBI chr 1:199,926,150...199,952,847
|
|
G |
Mvb12a |
multivesicular body subunit 12A |
|
ISO |
ClinVar Annotator: match by term: Human immunodeficiency virus type 1, rapid progression to AIDS |
ClinVar |
|
|
NCBI chr16:18,252,227...18,257,111
|
|
G |
Myh9 |
myosin, heavy chain 9 |
|
ISO |
protein:decreased expression:glomerulus |
RGD |
PMID:22313957 |
RGD:6903274 |
NCBI chr 7:111,224,291...111,304,963
|
|
G |
Nefl |
neurofilament light chain |
treatment |
ISO |
|
RGD |
PMID:30005007 |
RGD:127285390 |
NCBI chr15:46,477,330...46,481,203
|
|
G |
Nefm |
neurofilament medium chain |
|
ISO |
protein:increased serine/threonine phosphorylation:brain |
RGD |
PMID:26033855 |
RGD:40886309 |
NCBI chr15:46,535,857...46,541,161
|
|
G |
Nup88 |
nucleoporin 88 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr10:55,667,903...55,692,249
|
|
G |
Nutf2 |
nuclear transport factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr19:33,752,319...33,773,595
|
|
G |
Odc1 |
ornithine decarboxylase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12878215 |
|
NCBI chr 6:46,058,439...46,065,148
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29709520 |
|
NCBI chr 4:148,030,237...148,037,599
|
|
G |
Oprm1 |
opioid receptor, mu 1 |
|
IEP |
mRNA:increased expression:macrophage |
RGD |
PMID:17553897 |
RGD:2316609 |
NCBI chr 1:45,565,371...45,818,722
|
|
G |
Pdcd1 |
programmed cell death 1 |
|
ISO |
|
RGD |
PMID:30161254 |
RGD:41412179 |
NCBI chr 9:101,866,124...101,879,278
|
|
G |
Pla2g2a |
phospholipase A2 group IIA |
|
ISO |
|
RGD |
PMID:18096355 |
RGD:6482728 |
NCBI chr 5:156,359,725...156,362,302
|
|
G |
Plaur |
plasminogen activator, urokinase receptor |
disease_progression |
ISO |
protein:increased expression:plasma |
RGD |
PMID:21384094 PMID:20229356 |
RGD:6484120, RGD:6484128 |
NCBI chr 1:89,181,363...89,196,308
|
|
G |
Pomc |
proopiomelanocortin |
|
ISO |
mRNA:decreased expression:striatum |
RGD |
PMID:20651230 |
RGD:407571693 |
NCBI chr 6:32,659,137...32,665,175
|
|
G |
Ppia |
peptidylprolyl isomerase A |
disease_progression |
ISO |
DNA:SNPs:promotor, intron 1: 1604C>G, 2653A>C (rs8177826, rs3735481) (human) |
RGD |
PMID:17590083 |
RGD:150383341 |
NCBI chr14:81,279,292...81,282,960
|
|
G |
Ppib |
peptidylprolyl isomerase B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 8:66,603,877...66,609,734
|
|
G |
Prf1 |
perforin 1 |
|
ISO |
DNA:SNP: :rs885822 (human) |
RGD |
PMID:20523897 PMID:21157294 |
RGD:6482808, RGD:6482819 |
NCBI chr20:29,246,202...29,251,712
|
|
G |
Prpf8 |
pre-mRNA processing factor 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr10:60,331,494...60,354,606
|
|
G |
Psma4 |
proteasome 20S subunit alpha 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 8:64,236,520...64,243,980
|
|
G |
Psma5 |
proteasome 20S subunit alpha 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 2:195,896,369...195,919,733
|
|
G |
Psma6 |
proteasome 20S subunit alpha 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 6:78,500,676...78,531,693
|
|
G |
Psmb10 |
proteasome 20S subunit beta 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr19:33,830,958...33,833,442
|
|
G |
Psmb4 |
proteasome 20S subunit beta 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 2:182,442,757...182,445,532
|
|
G |
Psmc3 |
proteasome 26S subunit, ATPase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 3:77,031,825...77,037,207
|
|
G |
Psmc5 |
proteasome 26S subunit, ATPase 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr10:91,187,763...91,193,697
|
|
G |
Psmd13 |
proteasome 26S subunit, non-ATPase 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 1:195,964,617...195,976,895
|
|
G |
Psmd3 |
proteasome 26S subunit, non-ATPase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr10:84,139,249...84,151,879
|
|
G |
Psmd6 |
proteasome 26S subunit, non-ATPase 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr15:11,102,174...11,112,180
|
|
G |
Psmd8 |
proteasome 26S subunit, non-ATPase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 1:93,601,857...93,608,689
|
|
G |
Psme1 |
proteasome activator subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr15:29,069,012...29,071,888
|
|
G |
Psme2 |
proteasome activator subunit 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr15:29,078,495...29,082,794
|
|
G |
Psme3 |
proteasome activator subunit 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr10:86,757,933...86,765,719
|
|
G |
Psme4 |
proteasome activator subunit 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr14:108,706,643...108,810,330
|
|
G |
Ptch1 |
patched 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12878215 |
|
NCBI chr17:1,548,449...1,613,461
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
IEP |
mRNA, protein:increased expression:brain |
RGD |
PMID:21846384 |
RGD:5508195 |
NCBI chr13:64,714,063...64,722,320
|
|
G |
Rab11b |
RAB11B, member RAS oncogene family |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 7:15,223,613...15,236,754
|
|
G |
Rab32 |
RAB32, member RAS oncogene family |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 1:4,946,193...4,961,003
|
|
G |
Ran |
RAN, member RAS oncogene family |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr12:27,674,049...27,678,598
|
|
G |
Ranbp1 |
RAN binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr11:96,246,912...96,255,145
|
|
G |
RT1-Ba |
RT1 class II, locus Ba |
|
ISO |
DNA:polymorphisms (human) |
RGD |
PMID:18427198 |
RGD:5147817 |
NCBI chr20:4,575,134...4,579,727
|
|
G |
RT1-Bb |
RT1 class II, locus Bb |
|
ISO |
DNA:polymorphisms: :multiple (human) DNA:polymorphisms (human) |
RGD |
PMID:20345872 PMID:18427198 |
RGD:5147659, RGD:5147817 |
NCBI chr20:4,598,475...4,604,118
|
|
G |
RT1-Da |
RT1 class II, locus Da |
|
ISO |
|
RGD |
PMID:21427211 |
RGD:5490157 |
NCBI chr20:4,513,464...4,518,457
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
disease_progression susceptibility |
ISO |
DNA:polymorphism (human) DNA:polymorphism:cds:HLA-DRB1*08, HLA-B*35, HLA-C*04 (human) DNA:polymorphisms: :multiple (human) |
RGD |
PMID:28244954 PMID:21257739 PMID:20345872 |
RGD:40903000, RGD:5147591, RGD:5147659 |
NCBI chr20:4,548,664...4,558,237
|
|
G |
Selp |
selectin P |
|
ISO |
|
RGD |
PMID:22156911 |
RGD:6218986 |
NCBI chr13:76,476,229...76,511,846
|
|
G |
Serpina1 |
serpin family A member 1 |
susceptibility |
ISO |
CTD Direct Evidence: therapeutic DNA:polymorphism:cds:p.Glu264Val(human) |
CTD RGD |
PMID:17448989 PMID:24122823 |
RGD:14695057 |
NCBI chr 6:128,631,101...128,653,125
|
|
G |
Sf3a3 |
splicing factor 3a, subunit 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 5:136,967,713...136,987,345
|
|
G |
Sfpq |
splicing factor proline and glutamine rich |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 5:139,338,034...139,353,476
|
|
G |
Sigmar1 |
sigma non-opioid intracellular receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16204638 |
|
NCBI chr 5:56,904,155...56,907,012
|
|
G |
Sirt1 |
sirtuin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19720090 |
|
NCBI chr20:25,305,953...25,328,000
|
|
G |
Slc11a1 |
solute carrier family 11 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16597321 |
|
NCBI chr 9:75,957,193...75,968,115
|
|
G |
Snrpd3 |
small nuclear ribonucleoprotein D3 polypeptide |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr20:13,130,112...13,145,947
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
|
ISO |
mRNA:decreased expression:uterine cervix |
RGD |
PMID:16878360 |
RGD:2298904 |
NCBI chr10:5,389,574...5,391,265
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
|
ISO |
mRNA:decreased expression:uterine cervix |
RGD |
PMID:16878360 |
RGD:2298904 |
NCBI chr10:103,692,579...103,695,975
|
|
G |
Srf |
serum response factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 9:21,924,050...21,933,338
|
|
G |
Srsf1 |
serine and arginine rich splicing factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr10:73,335,519...73,342,549
|
|
G |
Srsf9 |
serine and arginine rich splicing factor 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr12:41,278,225...41,284,502
|
|
G |
Sting1 |
stimulator of interferon response cGAMP interactor 1 |
|
ISO |
mRNA:increased expression:multiple tissues (human) |
RGD |
PMID:24367701 |
RGD:39128218 |
NCBI chr18:27,606,196...27,612,544
|
|
G |
Taf9 |
TATA-box binding protein associated factor 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 2:33,528,388...33,532,395
|
|
G |
Tlr3 |
toll-like receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Human immunodeficiency virus type 1, susceptibility to |
CTD OMIM ClinVar |
PMID:17872438 PMID:19625408 PMID:20472559 PMID:20855885 PMID:21911422 PMID:22174453 PMID:24033266 PMID:25339207 PMID:25741868 PMID:26193622 PMID:28046022 PMID:28492532 PMID:29217828 PMID:29305044 PMID:31217193 PMID:33174085 PMID:34813006 More...
|
|
NCBI chr16:53,554,916...53,572,321
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:1768380 |
RGD:10449449 |
NCBI chr20:3,626,685...3,629,303
|
|
G |
Tnfrsf8 |
TNF receptor superfamily member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8811349 |
|
NCBI chr 5:157,123,183...157,168,421
|
|
G |
Trem1 |
triggering receptor expressed on myeloid cells 1 |
|
ISO |
mRNA,protein:increased expression:peripheral blood mononuclear cell, macrophage, plasma |
RGD |
PMID:31260499 |
RGD:126925971 |
NCBI chr 9:20,259,227...20,276,879
|
|
G |
Trim5 |
tripartite motif-containing 5 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15249687 |
|
NCBI chr 1:158,720,407...158,737,393
|
|
G |
U2af1 |
U2 small nuclear RNA auxiliary factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr20:9,742,904...9,753,840
|
|
G |
Vdr |
vitamin D receptor |
|
ISO |
DNA:SNPs:3' UTR (human) |
RGD |
PMID:18712587 |
RGD:4889839 |
NCBI chr 7:130,864,764...130,916,757
|
|
G |
Yy1 |
YY1 transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15308739 |
|
NCBI chr 6:133,471,615...133,500,875
|
|
|
G |
Nefl |
neurofilament light chain |
disease_progression |
ISO |
protein:increased expression:CSF (human) |
RGD |
PMID:32117023 |
RGD:127285386 |
NCBI chr15:46,477,330...46,481,203
|
|
G |
Trem2 |
triggering receptor expressed on myeloid cells 2 |
disease_progression |
ISO |
protein:increased expression:CSF (human) |
RGD |
PMID:32117023 |
RGD:127285386 |
NCBI chr 9:12,647,605...12,654,190
|
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
|
ISO |
|
RGD |
PMID:18008231 |
RGD:8551830 |
NCBI chr 8:132,629,097...132,660,980
|
|
G |
Foxp3 |
forkhead box P3 |
treatment |
ISO |
|
RGD |
PMID:27284313 |
RGD:38456006 |
NCBI chr X:17,580,380...17,601,181
|
|
G |
Nefl |
neurofilament light chain |
|
ISO |
associated with age;protein:increased expression:CSF (human) |
RGD |
PMID:32117023 |
RGD:127285386 |
NCBI chr15:46,477,330...46,481,203
|
|
G |
Trem2 |
triggering receptor expressed on myeloid cells 2 |
|
ISO |
associated with age;protein:increased expression:CSF (human) |
RGD |
PMID:32117023 |
RGD:127285386 |
NCBI chr 9:12,647,605...12,654,190
|
|
|
G |
Il10 |
interleukin 10 |
no_association severity |
ISO |
protein:increased expression:tear DNA:SNP:promoter:−1082G>A (human) DNA:SNP:promoter:−819T>C, −592A>C (human) DNA:SNP, haplotype:promoter:−1082G>A (human) DNA:haplotype: : |
RGD |
PMID:18628987 PMID:11023480 PMID:11023480 PMID:15789056 PMID:17947295 |
RGD:7365037, RGD:7365085, RGD:7365085, RGD:7365072, RGD:7365053 |
NCBI chr13:45,024,921...45,029,586
|
|
G |
Il17a |
interleukin 17A |
|
ISO |
mRNA:increased expression:conjunctiva (human) |
RGD |
PMID:21911461 |
RGD:9068420 |
NCBI chr 9:30,640,844...30,644,331
|
|
G |
RT1-CE13 |
RT1 class I, locus CE13 |
|
ISO |
DNA:polymorphisms:cds:HLA-B*14 (human, Tanzanian) |
RGD |
PMID:18824733 |
RGD:7364877 |
NCBI chr20:3,314,491...3,322,815
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
DNA:SNP, haplotypes:promoter:−308G>A (human) |
RGD |
PMID:17330135 |
RGD:8548830 |
NCBI chr20:3,626,685...3,629,303
|
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
|
ISO |
mRNA:decreased expression:tarsal conjunctiva (human) |
RGD |
PMID:20375326 |
RGD:8552676 |
NCBI chr10:80,380,458...80,397,461
|
|